Knee Steroid Injection and Blood Sugar Signatur
Status
Conditions
Treatments
Details and patient eligibility
About
A prospective, observational study assessing the relationship between HbA1c level and the post-injection blood glucose signature. Participants will be non-diabetic, pre-diabetic, non-insulin dependent and insulin dependent type 2 diabetic patients who will be receiving a knee steroid injection. All of them will be consented a week prior to the injection, when the CGM sensor will be applied to the back of the upper arm. This will be removed a week after the injection. KOOS survey as well as VAS will be administered. Adverse events (e.g., change in medication or hospitalization) will be monitored throughout the study.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Patients at the Parkland Outpatient Clinic
- Indication for unilateral knee joint steroid injection for the treatment of knee joint osteoarthritis
Exclusion criteria
- Less than 18 years old
- HbA1c > 12.0%
- steroid exposure in the 3 months prior to Visit 1
- 3 or more steroid injections in the preceding 12 months
- known contraindication to steroid injection (adverse reaction or allergy, active infection, INR > 3.0)
- lack of improvement with prior knee steroid injection
- change in diabetic medication regimen in the last 1 month
- significant change in diet within the last 1 month
- current use of aspirin
- allergy to adhesive
- planned MRI, XR, or CT during the 2-week study period
Trial design
11 participants in 3 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal